QIAGEN N.V.
QGEN
$39.48
$0.581.49%
Weiss Ratings | QGEN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | C | |||
Rating Factors | QGEN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Good | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | QGEN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.48 | |||
Price History | QGEN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 2.41% | |||
30-Day Total Return | -11.30% | |||
60-Day Total Return | -15.90% | |||
90-Day Total Return | -9.08% | |||
Year to Date Total Return | -14.18% | |||
1-Year Total Return | -13.17% | |||
2-Year Total Return | -20.83% | |||
3-Year Total Return | -18.56% | |||
5-Year Total Return | -5.98% | |||
52-Week High % Change | -21.09% | |||
52-Week Low % Change | 3.37% | |||
Price | QGEN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $49.30 | |||
52-Week Low Price | $37.63 | |||
52-Week Low Price (Date) | Mar 04, 2025 | |||
52-Week High Price (Date) | Jan 22, 2025 | |||
Valuation | QGEN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 8.41B | |||
Enterprise Value | 8.65B | |||
Price/Earnings (TTM) | 93.83 | |||
Earnings Per Share (TTM) | 0.41 | |||
Earnings Per Share Growth | -72.96% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 4.31 | |||
Price/Book (Q) | 2.38 | |||
Enterprise Value/Revenue (TTM) | 4.40 | |||
Price | $39.48 | |||
Enterprise Value/EBITDA (TTM) | 22.37 | |||
Enterprise Value/EBIT | 45.79 | |||
Market Cap Category | Mid Cap | |||
Dividends and Shares | QGEN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 217.81M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | $1.26 | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | $1.26 | |||
Company Info | QGEN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 31 77 355 6600 | |||
Address | -- | |||
Website | www.qiagen.com | |||
Country | Netherlands | |||
Year Founded | 1984 | |||
Profitability | QGEN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 9.60% | |||
Profit Margin | 4.72% | |||
Management Effectiveness | QGEN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 1.94% | |||
Return on Equity | 2.57% | |||
Income Statement | QGEN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 1.97B | |||
Total Revenue (TTM) | 1.97B | |||
Revenue Per Share | $9.03 | |||
Gross Profit (TTM) | 1.02B | |||
EBITDA (TTM) | 386.39M | |||
EBIT (TTM) | 188.81M | |||
Net Income (TTM) | 92.93M | |||
Net Income Avl. to Common (TTM) | 92.93M | |||
Total Revenue Growth (Q YOY) | 5.46% | |||
Earnings Growth (Q YOY) | 26.01% | |||
EPS Diluted (TTM) | 0.41 | |||
EPS Diluted Growth (Q YOY) | 25.55% | |||
Balance Sheet | QGEN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 1.48B | |||
Cash Per Share (Q) | $6.80 | |||
Total Current Assets (Q) | 2.45B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 3.53B | |||
Current Ratio (Q) | 2.175 | |||
Book Value Per Share (Q) | $16.34 | |||
Total Assets (Q) | 6.27B | |||
Total Current Liabilities (Q) | 1.13B | |||
Total Debt (Q) | 2.01B | |||
Total Liabilities (Q) | 2.74B | |||
Total Common Equity (Q) | 3.53B | |||
Cash Flow | QGEN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -300.90M | |||
Cash from Financing (TTM) | 58.64M | |||
Net Change in Cash (TTM) | 393.05M | |||
Levered Free Cash Flow (TTM) | 219.87M | |||
Cash from Operations (TTM) | 633.41M | |||